Programa de detección de fallas de calidad en los medicamentos comercializados

Defective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a cente...

Full description

Bibliographic Details
Published in:Revista Panamericana de Salud Pública
Format: Article in Journal/Newspaper
Language:English
Spanish
Portuguese
Published: Pan American Health Organization 1999
Subjects:
R
Online Access:https://doi.org/10.1590/s1020-49891999000800014
https://doaj.org/article/40409e5565064ef4b029efae7d21537f
Description
Summary:Defective drugs have been found during the postmarketing phase in various countries, regardless of those nations' level of economic development. This paper proposes guidelines for a program to uncover drug defects in the postmarketing surveillance period. Such a program should be run by a center or service organized for that purpose within the framework of a national drug surveillance system.